Assessment of corticosteroids in prevention and treatment of neonatal bronchopulmonary dysplasia
10.3760/cma.j.issn.2095-428X.2017.14.003
- VernacularTitle:糖皮质激素在新生儿支气管肺发育不良防治中的评价
- Author:
Zhifeng HUANG
;
Chuanzhong YANG
- Keywords:
Bronchopulmonary dysplasia;
Corticosteroids;
Infant,premature
- From:
Chinese Journal of Applied Clinical Pediatrics
2017;32(14):1051-1054
- CountryChina
- Language:Chinese
-
Abstract:
There is a great controversy over the application of corticosteroids in preventing and treating bronchopulmonary dysplasia(BPD).Prenatal use of corticosteroids may reduce the occurrence of BPD.Intravenous corticosteroids within 1 week after birth can reduce the incidence of BPD.However,in light of the short and long-term adverse reactions,it is not recommended.For premature infants with BPD in high risk,clinicians should weigh the pros and cons and may apply a small dose,short course of corticosteroids for intervention in 1 week after birth.Early inhalation or instilling of corticosteroids may be an effective and safe way to reduce the occurrence of BPD.
